| 22nd Jun 2022 7:00 am |
RNS |
Result of Placing and Total Voting Rights |
| 21st Jun 2022 4:41 pm |
RNS |
Proposed Placing to raise at least £1.5 million |
| 17th Jun 2022 12:00 pm |
RNS |
NetScientific to increase Q-Bot stake to 23.7% |
| 15th Jun 2022 7:00 am |
RNS |
Q-Bot secures £1.6m of investment to fund growth |
| 7th Jun 2022 11:07 am |
RNS |
Notice of AGM and Annual Report & Accounts |
| 6th Jun 2022 7:00 am |
RNS |
PDS Granted FDA Fast Track Designation for PDS0101 |
| 27th May 2022 2:39 pm |
RNS |
PDS Biotech - new data for ongoing clinical trials |
| 19th May 2022 7:00 am |
RNS |
General Counsel Strategic Hire & Grant of Options |
| 16th May 2022 7:00 am |
RNS |
ProAxsis Update |
| 12th May 2022 7:00 am |
RNS |
Final Results |
| 11th May 2022 3:46 pm |
RNS |
PDS Reports Q1 2022 Results & Business Update |
| 9th May 2022 7:00 am |
RNS |
Notice of Results & Investor Presentation |
| 6th May 2022 7:00 am |
RNS |
Acquisition of 30% of Vortex Biotech Holdings |
| 25th Apr 2022 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 25th Apr 2022 2:00 pm |
RNS |
Price Monitoring Extension |
| 25th Apr 2022 11:05 am |
RNS |
Second Price Monitoring Extn |
| 25th Apr 2022 11:00 am |
RNS |
Price Monitoring Extension |
| 31st Mar 2022 1:24 pm |
RNS |
PDS Provides Business Update & Full-Year Results |
| 4th Mar 2022 7:30 am |
RNS |
Publication of Shareholder Newsletter |
| 24th Feb 2022 4:45 pm |
RNS |
PDS Announces Preliminary Safety Data on PDS0101 |
| 15th Feb 2022 2:32 pm |
RNS |
PDS Clinical Trial with Mayo Clinic |
| 2nd Feb 2022 3:00 pm |
RNS |
PDS Phase 2 Trial Update |
| 28th Jan 2022 8:45 am |
RNS |
PDS Announces Preclinical Data for PDS0202 Vaccine |
| 18th Jan 2022 7:00 am |
RNS |
Holding(s) in Company |
| 10th Jan 2022 2:20 pm |
RNS |
PDS Granted Novel HPV16 Immunotherapy Patent |
| 10th Jan 2022 7:00 am |
RNS |
ProAxsis CEO End of Year Update |
| 29th Dec 2021 8:47 am |
RNS |
Issue of Equity |
| 21st Dec 2021 1:59 pm |
RNS |
TR-1: Form for notification of major holdings |
| 21st Dec 2021 7:00 am |
RNS |
Q-Bot Investment and Share Acquisition |
| 20th Dec 2021 7:00 am |
RNS |
Acquisition of majority stake in Cetromed |
| 13th Dec 2021 7:00 am |
RNS |
Martlet Capital Update |
| 6th Dec 2021 2:53 pm |
RNS |
PDS Phase 2 Clinical Trial Update |
| 26th Nov 2021 7:00 am |
RNS |
$1million investment in portfolio company, EpiBone |
| 10th Nov 2021 1:58 pm |
RNS |
PDS Reports Q3 2021 Results & Business Update |
| 4th Nov 2021 7:00 am |
RNS |
Sofant Signs EUR7.3m ESA Contract |
| 1st Nov 2021 2:16 pm |
RNS |
PDS to License Novel Proteins for Flu Vaccine |
| 26th Oct 2021 7:00 am |
RNS |
EMV Capital Participates in £843k Sofant Funding |
| 22nd Oct 2021 11:18 am |
RNS |
ProAxsis announces the approval of a key US patent |
| 22nd Oct 2021 9:04 am |
RNS |
Holding(s) in Company |
| 21st Oct 2021 4:40 pm |
RNS |
Second Price Monitoring Extn |
